Focus: Neuroelectrics is a Spain-based neurostimulation device company focused on transcranial direct current stimulation (tDCS) and related neuromodulation technologies for neurology and metabolic disorders. The company operates as a publicly traded entity with a lean footprint and diversified clinical pipeline across depression, epilepsy, stroke, and obesity.
Profile data last refreshed 4h ago · AI intelligence enriched 3w ago
Stable — net -2 jobs in 30d
1 added, 3 removed. Backfill posture.
Neuroelectrics offers career upside in an innovative neurotech space with public-market credibility, but hiring stasis and lack of financial transparency suggest cautious growth or potential consolidation risk.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Neuroelectrics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Neuroelectrics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles